Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy

Abstract Background Corticosteroids are routinely utilized to alleviate edema in patients with intracranial lesions and are first-line agents to combat immune-related adverse events (irAEs) that arise with immune checkpoint blockade treatment. However, it is not known if or when corticosteroids can...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Amber J. Giles, Marsha-Kay N. D. Hutchinson, Heather M. Sonnemann, Jinkyu Jung, Peter E. Fecci, Nivedita M. Ratnam, Wei Zhang, Hua Song, Rolanda Bailey, Dionne Davis, Caitlin M. Reid, Deric M. Park, Mark R. Gilbert
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BMJ Publishing Group 2018-06-01
Reeks:Journal for ImmunoTherapy of Cancer
Onderwerpen:
Corticosteroids
Immunotherapy
Glioma
Checkpoint blockade
Dexamethasone
Online toegang:http://link.springer.com/article/10.1186/s40425-018-0371-5
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items